Literature DB >> 11023406

A Giardia duodenalis gene encoding a protein with multiple repeats of a toxin homologue.

N Chen1, J A Upcroft, P Upcroft.   

Abstract

A gene, CRP136, from the intestinal protozoan parasite Giardia duodenalis, expressed at a high level in a metronidazole-resistant line, encodes a 136 kDa protein with 23 copies of a 40 amino acid repeat. The protein is cysteine-rich and has the typical membrane-spanning region and CXXC amino acid motifs of a family of Giardia cysteine-rich surface proteins (CRSPs). The repeat unit in CRP136, shares 57% homology with the gene encoding the precursor of the sarafotoxins, a group of snake toxins from the burrowing adder known to cause symptoms similar to those of humans acutely infected with Giardia. The sarafotoxins are low molecular weight sulphydryl cross-linked peptides which are proteolytically cleaved from a precursor polyprotein. CRP136 has homology over the entire length of the sarafotoxin precursor, and the repeats are of the same length. Thus CRP136 represents the first evidence for a potential Giardia toxin. The genomic copy number of CRP136 appears to be the same in both the parent and drug-resistant lines and expression of this gene, and at least one other, is associated with a conserved partial duplication, but not amplification, of one chromosome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 11023406     DOI: 10.1017/s0031182000065926

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  12 in total

Review 1.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 2.  Mechanisms of epithelial dysfunction in giardiasis.

Authors:  Andre G Buret
Journal:  Gut       Date:  2007-03       Impact factor: 23.059

3.  Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response.

Authors:  L A Dunn; J A Upcroft; E V Fowler; B S Matthews; P Upcroft
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 4.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

5.  Intermediate subunit of the Gal/GalNAc lectin of Entamoeba histolytica is a member of a gene family containing multiple CXXC sequence motifs.

Authors:  X J Cheng; M A Hughes; C D Huston; B Loftus; C A Gilchrist; L A Lockhart; S Ghosh; V Miller-Sims; B J Mann; W A Petri; H Tachibana
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Goblet cells: are they an unspecific barrier against Giardia intestinalis or a gate?

Authors:  Martha Ponce-Macotela; Angélica González-Maciel; Rafael Reynoso-Robles; Mario N Martínez-Gordillo
Journal:  Parasitol Res       Date:  2007-11-25       Impact factor: 2.289

7.  Systemic and mucosal responses to oral administration of excretory and secretory antigens from Giardia intestinalis.

Authors:  Juan Carlos Jiménez; Josette Fontaine; Jean-Marie Grzych; Eduardo Dei-Cas; Monique Capron
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

8.  Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner.

Authors:  Alex C Chin; Desiree A Teoh; Kevin G-E Scott; Jonathon B Meddings; Wallace K Macnaughton; Andre G Buret
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  The Giardia lamblia vsp gene repertoire: characteristics, genomic organization, and evolution.

Authors:  Rodney D Adam; Anuranjini Nigam; Vishwas Seshadri; Craig A Martens; Gregory A Farneth; Hilary G Morrison; Theodore E Nash; Stephen F Porcella; Rima Patel
Journal:  BMC Genomics       Date:  2010-07-09       Impact factor: 3.969

10.  Draft genome sequencing of giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species?

Authors:  Oscar Franzén; Jon Jerlström-Hultqvist; Elsie Castro; Ellen Sherwood; Johan Ankarklev; David S Reiner; Daniel Palm; Jan O Andersson; Björn Andersson; Staffan G Svärd
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.